Clinical Trials Directory

Trials / Completed

CompletedNCT04759040

Improvement of Migraine Severity and Frequency With Migraineguard ™

Migraineguard ™ Supplement Reduces the Severity and Frequency of Migraine , a Randomized, Placebo-controlled, Double-blind, Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Herbacure Natural · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Numerous treatments have been recommended for the prevention of migraine. The purpose of this randomized double-blind placebo controlled trial was to assess the efficacy of MIGRAINEGUARD ™ supplement by Herbacure Natural containing a combination of COQ10 , magnesium, riboflavin ,feverfew , Skullcap and black pepper as prophylactic treatment for migraine.

Detailed description

Our team will assess MIGRAINEGUARD ™ , a migraine prevention supplement marketed Herbacure Natural for individual suffering from multiple migraine attacks in one month . The purpose of this 7-months , randomized, double-blind, placebo controlled study is to evaluate the efficacy and safety of MIGRAINEGUARD ™ produced by Herbacure Natural , A Canadian company based in Vancouver , BC , in reducing migraine headache severity and frequency of attacks compared to placebo when used every day, as a preventative solution for migraine and to assess and monitor the safety of its usage for adverse effects. The primary end-point is the severity and the frequency reduction of migraine attacks. The secondary end-points will be the existence of adverse reaction.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMigraineguard2 Capsules per day for 7 Months

Timeline

Start date
2020-04-01
Primary completion
2020-10-31
Completion
2020-11-25
First posted
2021-02-17
Last updated
2021-03-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04759040. Inclusion in this directory is not an endorsement.